Arkolith/Insider Trading/LGND/Form 4

Kozarich John W

DirectorLIGAND PHARMACEUTICALS INC (LGND) · full profile →Form 4 · filed Apr 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$94K
Net Open-Market Flow
-$94K
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 1, 2026Sell(S)146$199.97$29K43K
Apr 1, 2026Sell(S)40$201.24$8K43K
Apr 1, 2026Sell(S)79$202.42$16K42K
Apr 1, 2026Sell(S)43$202.91$9K42K
Apr 1, 2026Sell(S)159$204.26$32K42K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002001011-26-000038) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML